Skip to main content Skip to section navigation Skip to footer
Avalon GloboCare Corp.
  • Home
  • About
    • Overview
    • Executive Team
    • Board of Directors
  • Core Platforms
  • Investors
    • Overview
    • News & Events
    • Company Information
    • Financial Information
    • Stock Data
    • SEC Filings
    • Corporate Governance
  • Contact

Press Releases

Investors

Investors

  • Overview
  • News & Events
    • Overview
    • Press Releases
    • IR Calendar
    • Presentations
    • Email Alerts
  • Company Information
    • Overview
    • Executive Team
    • Contacts
    • FAQ
  • Financial Information
    • Overview
    • Financial Results
    • Income Statement
    • Balance Sheet
    • Cash Flow
  • Stock Data
    • Quote
    • Charts
    • Historical Data
  • SEC Filings
    • Overview
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
  • Corporate Governance
    • Overview
    • Board of Directors
    • Board Committees
    • Governance Documents
    • Board Diversity Matrix
  • News & Events

  • Overview
  • Press Releases
  • IR Calendar
  • Presentations
  • Email Alerts
Oct 18, 2023 9:00am EDT

Avalon GloboCare Partners with Qi Diagnostics to Co-Develop International Multi-Center Clinical Studies for DKAir Breathalyzer Device for the Early Detection of Diabetic Ketoacidosis

Oct 04, 2023 9:00am EDT

Apple Approves Use of Avalon GloboCare’s KetoAir Mobile Application

Sep 13, 2023 9:15am EDT

Avalon’s Laboratory Services MSO Acquires California-Based Medical Supply Company and Proprietary FDA-Registered External Male Catheter Device

Sep 05, 2023 8:00am EDT

Avalon GloboCare Announces Notice of Publication for Key U.S. Patent Filed Jointly with the Massachusetts Institute of Technology (MIT)

Aug 30, 2023 9:00am EDT

Avalon’s Laboratory Services MSO Launches Innovative Laboratory Test for Tuberculosis

Aug 21, 2023 9:00am EDT

Avalon’s Laboratory Services MSO Announces Expansion into Arizona

Jul 24, 2023 9:00am EDT

Avalon’s Laboratory Services MSO Acquires Texas Lab with Significant Potential Growth

Jul 19, 2023 9:00am EDT

Avalon GloboCare’s Laboratory Services MSO Signs Exclusive In-Network Lab Services Agreement Providing Significant Expansion Opportunity into 21 States

Jul 10, 2023 9:00am EDT

Avalon GloboCare Provides Update on New Commercial Strategy

Apr 27, 2023 9:00am EDT

Avalon GloboCare Reports Laboratory Services MSO Revenue of $14.7 Million and Net Income of $6.3 Million in 2022

  • Previous Pagearrow_back
  • Page 1
  • Page 2
  • Page 3
  • Page 4
  • Page 5
  • Page 6
  • Page 7
  • Page 8
  • Page 9
  • Page 10
  • …
  • Page 13
  • Next Pagearrow_forward
rss_feed News RSS
  • Email Alerts
  • Company Profile
  • Contacts
  • RSS News Feed
©2025 Avalon GloboCare Corp. All Rights Reserved.
Privacy Policy Disclaimer Sitemap Manage Cookie Preferences